The report is titled as ‘Biologic Excipients Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the biologic excipients market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The biologic excipients market is expected to grow at a significant rate in the near future.
The global biologic excipients market in 2020 is estimated for more than US$ 1,245.3 Mn and expected to reach at a value of US$ 1,630.6 Mn by 2028 with a significant CAGR of 3.4%.
Increase in focus of market players on the bio-generic market, cost-effectiveness factor along with intense competition among the manufacturers, issues linked with the patents like the expiry of biological actives, and the mounting adoption of multi-purpose nature and functionality excipients are the prime factors supporting the market growth globally. Besides, the on-going research studies with the technological advancements to enhance the capability of the end product of bioavailability using excipients coupled with the growing demand for generic medicines from developing countries propelling the production of local drugs and the uptake of biologics resulting in driving demand for parenteral formulation are also expected to boost the biologic excipients market during the forecast period. Rising acquisition of contract research organizations, penetrating demand for the oral solid-liquid formulation, emerging adoption of technologies for advanced drug delivery systems, and the ability of biologic excipients to enhance solubility and bioavailability are other concerning factors fuelling the market growth.
Growing demand for generic drugs also positively impacts the market growth. For instance, the majority of the Indian population depends on generic drugs as they are available at low prices and have resulted in maximum efficacy in treating chronic diseases, thereby, boosting the demand for biologic excipients. However, the factors like the dearth of proper data documentation on GRAS, regulatory audits hampering the supply capacity, and the regulatory hurdles deterring the innovation of novel excipient restricts the market growth. On the contrary, the unstable focus of pharmaceutical manufacturing in emerging regions, like the Asia Pacific and the Middle East serves to offer lucrative growth opportunities for the market.
The biologic excipients market is segmented on the basis of excipient type, end-user, and by region.
Polymers
Sugar Alcohols
Polysorbates
Inorganic Salts
Amino Acids
Surfactants
Others
Biopharmaceutical Manufacturers
Contract Research Organizations/Contract Manufacturing Organizations
Research Organizations
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
The global biologics excipients market is driven by assisting the controlled or sustained release of delivery performance, the introduction of inventive technologies focusing on the targeted pediatric along with the geriatric patient pool, increasing implementation of increased patient-centricity approaches by drug manufacturers, and the mounting demand for extended-release or sustained-release formulations. However, the stability testing of excipients imposing the cost liabilities on market key manufacturers is likely to limit the growth of the biologic excipients market.
Moreover, factors like the growing biosimilars market and the extensive application of active ingredients in the manufacturing of pharmaceutical products are the major trends resulting in market growth.
Key players operating in the global biologic excipients market include:
Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
Roquette Frères
Signet Chemical Corporation Pvt. Ltd.
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
On the basis of region, the biologic excipients market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Biologic Excipients market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Biologic Excipients
• Advantage of Biologic Excipients over other modalities
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market
1. Global Biologic Excipients Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Biologic Excipients Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Biologic Excipients Market Snapshot
2.4. Global Biologic Excipients Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Biologic Excipients Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Biologic Excipients Market, By Excipient Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Excipient Type
3.1.2. BPS Analysis, By Excipient Type
3.2. Market Revenue (US$Mn) Forecast, By Excipient Type
3.2.1. Polymers
3.2.2. Sugar Alcohols
3.2.3. Polysorbates
3.2.4. Inorganic Salts
3.2.5. Amino Acids
3.2.6. Surfactants
3.2.7. Others
3.3. Global Biologic Excipients Market Attractiveness Index, By Excipient Type
4. Global Biologic Excipients Market, By End Users
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By End Users
4.1.2. BPS Analysis, By End Users
4.2. Market Revenue (US$Mn) Forecast, By End Users
4.2.1. Biopharmaceutical Manufacturers
4.2.2. Contract Research Organizations/Contract Manufacturing Organizations
4.2.3. Research Organizations
4.3. Global Biologic Excipients Market Attractiveness Index, By End Users
5. Global Biologic Excipients Market, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East
5.2.6. Africa
5.3. Global Biologic Excipients Market Attractiveness Index, By Region
6. North America Biologic Excipients Market Analysis and Forecast, 2020–2028
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) Forecast, By Country
6.2.1. U.S. Biologic Excipients Market
6.2.2. Canada Biologic Excipients Market
6.3. North America Biologic Excipients Market, By Excipient Type
6.3.1. Polymers
6.3.2. Sugar Alcohols
6.3.3. Polysorbates
6.3.4. Inorganic Salts
6.3.5. Amino Acids
6.3.6. Surfactants
6.3.7. Others
6.4. North America Biologic Excipients Market, By End Users
6.4.1. Biopharmaceutical Manufacturers
6.4.2. Contract Research Organizations/Contract Manufacturing Organizations
6.4.3. Research Organizations
6.5. North America Biologic Excipients Market Attractiveness Index
6.5.1. By Country
6.5.2. By End Users
6.5.3. By Excipient Type
7. Latin America Biologic Excipients Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) Forecast, By Country
7.2.1. Brazil Biologic Excipients Market
7.2.2. Mexico Biologic Excipients Market
7.2.3. Argentina Biologic Excipients Market
7.2.4. Rest of Latin America Biologic Excipients Market
7.3. Latin America Biologic Excipients Market, By Excipient Type
7.3.1. Polymers
7.3.2. Sugar Alcohols
7.3.3. Polysorbates
7.3.4. Inorganic Salts
7.3.5. Amino Acids
7.3.6. Surfactants
7.3.7. Others
7.4. Latin America Biologic Excipients Market, By End Users
7.4.1. Biopharmaceutical Manufacturers
7.4.2. Contract Research Organizations/Contract Manufacturing Organizations
7.4.3. Research Organizations
7.5. Latin America Biologic Excipients Market Attractiveness Index
7.5.1. By Country
7.5.2. By End Users
7.5.3. By Excipient Type
8. Europe Biologic Excipients Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. U.K. Biologic Excipients Market
8.2.2. Germany Biologic Excipients Market
8.2.3. Italy Biologic Excipients Market
8.2.4. France Biologic Excipients Market
8.2.5. Spain Biologic Excipients Market
8.2.6. Russia Biologic Excipients Market
8.2.7. Poland Biologic Excipients Market
8.2.8. BENELUX Biologic Excipients Market
8.2.9. NORDIC Biologic Excipients Market
8.2.10. Rest of Europe Biologic Excipients Market
8.3. Europe Biologic Excipients Market, By Excipient Type
8.3.1. Polymers
8.3.2. Sugar Alcohols
8.3.3. Polysorbates
8.3.4. Inorganic Salts
8.3.5. Amino Acids
8.3.6. Surfactants
8.3.7. Others
8.4. Europe Biologic Excipients Market, By End Users
8.4.1. Biopharmaceutical Manufacturers
8.4.2. Contract Research Organizations/Contract Manufacturing Organizations
8.4.3. Research Organizations
8.5. Europe Biologic Excipients Market Attractiveness Index
8.5.1. By Country
8.5.2. By End Users
8.5.3. By Excipient Type
9. Asia Pacific Biologic Excipients Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. China Biologic Excipients Market
9.2.2. India Biologic Excipients Market
9.2.3. Japan Biologic Excipients Market
9.2.4. Australia and New Zealand Biologic Excipients Market
9.2.5. South Korea Biologic Excipients Market
9.2.6. ASEAN Biologic Excipients Market
9.2.7. Rest of Asia Pacific Biologic Excipients Market
9.3. Asia Pacific Biologic Excipients Market, By Excipient Type
9.3.1. Polymers
9.3.2. Sugar Alcohols
9.3.3. Polysorbates
9.3.4. Inorganic Salts
9.3.5. Amino Acids
9.3.6. Surfactants
9.3.7. Others
9.4. Asia Pacific Biologic Excipients Market, By End Users
9.4.1. Biopharmaceutical Manufacturers
9.4.2. Contract Research Organizations/Contract Manufacturing Organizations
9.4.3. Research Organizations
9.5. Asia Pacific Biologic Excipients Market Attractiveness Index
9.5.1. By Country
9.5.2. By End Users
9.5.3. By Excipient Type
10. Middle East Biologic Excipients Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. GCC Countries Biologic Excipients Market
10.2.2. Israel Biologic Excipients Market
10.2.3. Oman Biologic Excipients Market
10.2.4. Rest of Middle East Biologic Excipients Market
10.3. Middle East Biologic Excipients Market, By Excipient Type
10.3.1. Polymers
10.3.2. Sugar Alcohols
10.3.3. Polysorbates
10.3.4. Inorganic Salts
10.3.5. Amino Acids
10.3.6. Surfactants
10.3.7. Others
10.4. Middle East Biologic Excipients Market, By End Users
10.4.1. Biopharmaceutical Manufacturers
10.4.2. Contract Research Organizations/Contract Manufacturing Organizations
10.4.3. Research Organizations
10.5. Middle East Biologic Excipients Market Attractiveness Index
10.5.1. By Country
10.5.2. By End Users
10.5.3. By Excipient Type
11. Africa Biologic Excipients Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. South Africa Biologic Excipients Market
11.2.2. Egypt Biologic Excipients Market
11.2.3. North Africa Biologic Excipients Market
11.2.4. Rest of Africa Biologic Excipients Market
11.3. Africa Biologic Excipients Market, By Excipient Type
11.3.1. Polymers
11.3.2. Sugar Alcohols
11.3.3. Polysorbates
11.3.4. Inorganic Salts
11.3.5. Amino Acids
11.3.6. Surfactants
11.3.7. Others
11.4. Africa Biologic Excipients Market, By End Users
11.4.1. Biopharmaceutical Manufacturers
11.4.2. Contract Research Organizations/Contract Manufacturing Organizations
11.4.3. Research Organizations
11.5. Africa Biologic Excipients Market Attractiveness Index
11.5.1. By Country
11.5.2. By End Users
11.5.3. By Excipient Type
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. Ashland Inc.
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. BASF Corporation
13.3.3. Colorcon Inc.
13.3.4. Evonik Industries
13.3.5. FMC Corporation
13.3.6. Roquette Frères
13.3.7. Signet Chemical Corporation Pvt. Ltd.
13.3.8. The Archer Daniels Midland Company
13.3.9. The Dow Chemical Company
13.3.10. Wacker Chemie AG
14. Acronyms